Australia's most trusted
source of pharma news
Friday, 17 October 2025
Posted 16 October 2025 AM
The pharmaceutical industry is teetering on the edge of an historic patent cliff that will see at least 69 blockbusters lose exclusivity putting more than US$300 billion in revenue at risk.
The analysis by pharma marketing researcher Dr Joanna Sadowska, known as Dr JoJo, garnered more than 750 reactions on LinkedIn in just 24 hours, indicating the level of concern across industry about the impact of looming patent losses.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.